Remove 2003 Remove Clinical Trials Remove Conditions Remove Sleep
article thumbnail

Bangkok Post Report: Cannabis clinics set to mushroom – currently 500 in operation

Cannabis Law Report

These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Department records show that the health condition of 74% of patients improves after such treatment. Most are cancer patients.

Oil 52
article thumbnail

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment

Cannabis Info

Dementia is a catch-all term for the conditions that cause declining memory and thinking skills, including Alzheimer’s, Parkinson’s and vascular dementia. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. Cannabis research in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Dr Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London.